Home Acessa Health Inc.

Acessa Health Inc.

    Acessa Health Inc. Announces Presentations at the 46th Annual AAGL Global Congress on Minimally Invasive Gynecology

    11/14/17: Acessa Health Inc., developer of the Acessa® System, an innovative laparoscopic radiofrequency ablation procedure for the treatment of uterine fibroids, announced today that four-year data along with community based evidence will be presented at the 46th Annual Global Congress on Minimally Invasive Gynecology Meeting, Nov. 12-16 in National Harbor, Greater Washington, D.C.

    New Evidence Points to Less Invasive Management for Women Suffering from Uterine Fibroids

    HOME The Journal of the Society of Laparoendoscopic Surgeons has released a publication led by Dr. Yelena Havryliuk and her colleagues from the...

    RECENT COMMENTS